Business Context and Reporting Period
This Form 8-K Current Report was filed by Illumina, Inc. on February 25, 2005. The report discloses the entry into a material definitive agreement regarding executive compensation under the company's 2000 Stock Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of stock option grants to executive officers.
Material Changes and Executive Compensation
The Compensation Committee approved the grant of stock options to the CEO and four other highly compensated officers. The grants are detailed below:
| Name and Title | Grant Date | Shares | Price per Share |
|---|---|---|---|
| Jay T. Flatley, President and CEO | February 25, 2005 | 200,000 | $8.60 |
| David L. Barker, VP and Chief Scientific Officer | February 25, 2005 | 40,000 | $8.60 |
| Noemi C. Espinosa, VP of Intellectual Property | February 25, 2005 | 30,000 | $8.60 |
| Timothy M. Kish, VP of Finance and CFO | March 2, 2005 | 70,000 | $8.24 |
| John R. Stuelpnagel, SVP and COO | February 25, 2005 | 125,000 | $8.60 |
Terms of Grant:
- Vesting: Ratably over 60 months from the grant date, subject to continuing service.
- Exercise Price: Equal to the closing price of common stock on the grant date.
- Term: Ten years from the grant date.
- Change of Control: Options become immediately fully vested and exercisable if the company is acquired and the options are not assumed by the acquiring entity.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, outlook, management commentary on operations, or specific risk factors beyond the standard terms of the stock plan.
Key Facts for Investor Verification
- Verify the total number of shares authorized under the 2000 Stock Plan to assess remaining capacity for future grants.
- Confirm the closing stock price on February 25, 2005, and March 2, 2005, to validate the exercise prices listed.
- Review the company's most recent 10-K or 10-Q for financial performance metrics, as this 8-K contains no operational financial data.
- Monitor future filings for any acceleration of vesting due to potential merger or asset sale activity.